Activity Overview
This video-based program is designed for eye care professionals to explore the management of neovascular age-related macular degeneration (nAMD) or diabetic macular edema (DME) using newer anti-VEGF agents with the potential for extended treatment intervals. This program places the patient’s voice front and center as an individual with nAMD shares his journey living with the condition and its treatment requirements.
Target Audience
This online educational activity is directed toward retina specialists and other eye care professionals involved in managing neovascular retinal diseases (ie, nAMD, DME).
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Identify unmet needs and treatment burden associated with conventional therapies for patients with DME and nAMD
- Evaluate recent clinical trials and real-world data on the safety, effectiveness, and durability of the ranibizumab port delivery system and other anti-VEGF therapies for patients with DME and nAMD
- Apply best practices to guide the use of the ranibizumab port delivery system and other anti-VEGF therapies when managing patients with DME and nAMD
John Kitchens, MD
Retina Associates of Kentucky
Eye Care Partners
Lexington, KY
Disclosures: Advisor, Consultant, Fee for Service Recipient: Alcon, Apellas, Astellas, Bayer, Roche Speakers Bureau: Apellas, Astellas, Bayer, Roche, Regeneron Ownership in Public Traded Companies: Vortex Surgical
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
